User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 12:34, 17 July 2017
, 17 July 2017→CBG: on w:Cannabigerol
imported>Jukeboksi |
imported>Jukeboksi (→CBG: on w:Cannabigerol) |
||
| Line 98: | Line 98: | ||
=== CBG === | === CBG === | ||
[[w:Cannabigerol|Cannabigerol]] | [[w:Cannabigerol|Cannabigerol]] has been shown to promote [[w:apoptosis|apoptosis]] in cancer cells and inhibit tumor growth in mice. It acts as an [[w:a2-adrenergic receptor|α<sub>2</sub>-adrenergic receptor]] agonist, [[w:5-HT1A receptor|5-HT<sub>1A</sub> receptor]] antagonist, and CB<sub>1</sub> receptor antagonist.<ref name="pmid20002104">{{cite journal|doi=10.1111/j.1476-5381.2009.00515.x |title=Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist |year=2010 |last1=Cascio |first1=MG |last2=Gauson |first2=LA |last3=Stevenson |first3=LA |last4=Ross |first4=RA |last5=Pertwee |first5=RG |journal=British Journal of Pharmacology |volume=159 |pages=129–41 |pmid=20002104 |issue=1 |pmc=2823359}}</ref> It also binds to the CB<sub>2</sub> receptor.<ref name="pmid20002104" /> | ||
=== CBC === | === CBC === | ||